RE: Lilly, Novo Nordisk gird for diabetes drug ba
Yup they sure are going for it Al.
BYETTA Sales last year $650,000,000.00. Expected Sales this year $1Billion.
Liraglutide Sales last year. $0.00. Expected sales this year piddly squat in revenue from sales in India.
Novo's GLP1 Analogue STILL NOT Approved. ELI LILLY's BYETTA moving to the next level of development already.
Cheers. Did you see Versant moved their Target up 37%.....to $23.50.
.